Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells
Mandy Beyer, Sven J. Henninger, Patricia S. Haehnel, Al‐Hassan M. Mustafa, Ece Gurdal, Bastian Schubert, Markus Christmann, Andreas Sellmer, Siavosh Mahboobi, Sebastian Drube, Wolfgang Sippl, Thomas Kindler, Oliver H. Krämer
Topics & Concepts
Fms-Like Tyrosine Kinase 3Myeloid leukemiaHaematopoiesisTyrosine kinasePhosphorylationTyrosineCD135Protein kinase domainCancer researchMutantLeukemiaKinaseTyrosine-kinase inhibitorTyrosine phosphorylationBruton's tyrosine kinaseChemistryReceptor tyrosine kinaseCell biologyBiologyBiochemistrySignal transductionImmunologyMutationGeneStem cellGeneticsCancerAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research